ROCHESTER, N.Y., Oct. 12, 2009 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (OTCBB:NNAN) (Frankfurt:N3N) Acting CEO and President James Wemett commented that "NaturalNano is taking a more aggressive approach to supplying Halloysite samples to researchers. We are changing the way we have been providing samples for research and feasibility studies. In the past, we have been supplying samples at a nominal cost; however, going forward, the Company will make small quantity samples available to Researchers on a cost-free basis to encourage them to more actively assess the benefits of the NaturalNano's Halloysite Natural Tubes (HNT)."
The NaturalNano decision is driven by a number of recent successes in feasibility studies which were significantly enhanced by the use of HNT in a variety of applications. NaturalNano recently announced a successful collaboration with Professor Michael King, Ph.D., of the Department of Biomedical Engineering at Cornell University in Ithaca, NY, who successfully incorporated using our Halloysite Natural Tubes to enhance the capture of cancer cells while being non-toxic to cancer cells. These experimental devices hold the potential for reducing or eliminating metastatic disease, the secondary spread of cancer beyond the initial tumor site. The King study and the role played by the HNT are described in an article available at http://www.news.cornell.edu/stories/June09/GeneTherapy.html.
Wemett added, "University innovation is the key to growing our economy and NaturalNano wants to encourage innovation and identify additional uses for HNT. This effort will accelerate commercialization. We at NaturalNano will benefit by potentially being a supplier once the technology is commercialized, and by being first in line to license technology."
Contact us at info@naturalnano.com with information in detail on your specific technology and your needs for free samples of our (HNT) Halloysite Natural Tubes. Our goal is to assist as many as we can with our HNT.
About NaturalNano, Inc.
NaturalNano, Inc. (OTCBB:NNAN) (Frankfurt:N3N) is a materials science company focused on developing and commercializing advanced nanocomposites. Based in Rochester, NY, the Company is focused on additive technologies and processes, including its proprietary Pleximer(TM) polymer additive, that add value to industrial polymers, plastics and composites, as well as consumer and industrial products. NaturalNano holds and licenses over 25 patents and applications, as well as proprietary know-how for extraction and separation processes, compositions, and derivatives of Halloysite and other nanotubes. Visit www.naturalnano.com for more information.
Cautionary Statement Regarding Forward-Looking Statements: This press release may contain forward-looking statements regarding future events and future performance of NaturalNano that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.